Skin disorders are present in many patients hospitalized in the intensive care unit. They range in severity from being the reason for admission to being a nuisance during care. These cutaneous problems have been categorized into four groups: (1) serious skin diseases that may incur life-threatening complications; (2) subtle skin problems associated with systemic disorders that may be characterized by critical events; (3) prominent cutaneous manifestations that accompany life-threatening systemic diseases; and (4) skin disorders that develop as complications during intensive care. Diseases in the first category were discussed in Part I of this article [1]. In Part II, we discuss diseases in the second category. The remaining disorders will be covered in Parts III and IV.
References
1.
Berman RS, Silvestri DL: Dermatologic problems in the intensive care unit. PartI. J Intensive Care Med1986;1:15-28
Fritzler MJ, Arlette JP, Behn AR, et al: Hereditary hemorrhagic telangiectasia vs. CREST syndrome: Can serology aid diagnosis?J Am Acad Dermatol1984;10:192-196
5.
Baranda MM, Perez M., De Andres J., et al: High output congestive heart failure as first manifestation of Osler-Weber-Rendu disease. J Vasc Dis1984 ;35:568-576
6.
Hodgson CH, Burchell HB, Good CA, et al: Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous fistula: Survey of a large family. N Engl J Med1959;261:625-636
7.
Reagan TJ, Bloom WH: The brain in hereditary hemorrhagic telangiectasia. Stroke1971;2:361-368
8.
Stanley RM, Hunter KR: Neurological manifestations of hereditary hemorrhagic telangiectasis . Br Med J1970;3:688
9.
Press OW, Ramsey PG: Central nervous system infections associated with hereditary hemorrhagic telangiectasia . Am J Med1984;77:86-92
10.
Childers RW , Rannizer K., Rabinowitz M.: Intrahepatic arteriovenous fistula with pulmonary vascular obstruction in Osler-Rendu-Weber disease. Am J Med1967;43:304-312
11.
Zelman S.: Liver fibrosis in hereditary hemorrhagic telangiectasia. Arch Path1972;74:66
12.
Smith JL, Lineback MR: Hereditary hemorrhagic telangiectasia: Nine cases in one Negro family with special reference to hepatic lesions. Am J Med1954;17:41-49
13.
Pandolfi M. , Ehinger B.: Conjunctival bleeding in Osler's disease with associated platelet dysfunction: A case report. Acta Ophthalmol1978;56:75-82
14.
Landau J., Nelken E., Davis E.: Hereditary haemorrhagic telangiectasia with retinal and conjunctival lesions . Lancet1956;2:230-231
15.
Harrison DF : Familial haemorrhagic telangiectasia: 20 cases treated with systemic estrogen. Q J Med1964 ;33:25-38
16.
Harrison DF : Hereditary haemorrhagic telangiectasia and oral contraceptives. Lancet1970;1:721
17.
Harris PW: Hereditary haemorrhagic telangiectasia and oral contraceptives. Lancet1970;1:615-616
18.
Rowley PT, Kurnick J., Cheville R.: Hereditary haemorrhagic telangiectasia: Aggravation by oral contraceptives?Lancet1970;1:474-475
19.
Richtsmeier W., Weaver G., Streck W., et al: Estrogen and progesterone receptors in hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg1984;92:564-570
20.
Parkin JL, Dickson JA: Argon laser treatment of head and neck vascular lesions. Otolaryngol Head Neck Surg1985;93:211-216
21.
Shapshay FM , Oliver P.: Treatment of hereditary hemorrhagic telangiectasia by Nd-YAG laser photo-coagulation. Laryngoscope1984;94:1554-1556
22.
Apfelberg DB , Mazer MR, Lash H., et al: Expanded role of the argon laser in plastic surgery. J Dermatol Surg1983;9:145-151
23.
Melski JW, Murphy GF: Case records of the Massachusetts General Hospital. N Engl J Med1980;303:1103-1111
Black MM, Hudson PM: Atrophie blanche lesions closely resembling malignant atrophic papulosis in systemic lupus erythematosus. Br J Dermatol1976; 95:649
31.
Su WP, Schroeder AL, Lee VA, et al: Clinical and histologic findings in Degos' syndrome (malignant atrophic papulosis). Cutis1985;35:131-138
32.
Soter NA, Murphy GF, Mihm MC Jr: Lymphocytes and necrosis of the cutaneous microvasculature in malignant atrophic papulosis: A fine light microscope study. J Am Acad Dermatol1982;7:620
33.
Lee DA, Su WP, Liesegane TJ: Ophthalmic changes of Degos' disease (malignant atrophic papulosis) . Ophthalmology1984;91:295-299
34.
Patterson JW : The perforating disorders. J Am Acad Dermatol1984;10:561-581
35.
Pyeritz RE: Cardiovascular manifestations of heritable disorders of connective tissue . Prog Med Genet1983;5:191-302
36.
Przybojewski JZ, Maritz F., Tiedt FAC, et al: Pseudoxanthoma elasticum with cardiac involvement: A case report and review of the literature . S Afr Med J1981;59:268-275
37.
Gubler MC, Antignac C., Broyer M., et al: Diffuse arterial calcified elastopathy—a new cause of renovascular hypertension in children. Int J Pediatr Nephrol1985;6:47-54
38.
Sykes EM Jr: Colon perforation in Ehlers-Danlos syndrome: Report of two cases and review of the literature. Am J Surg1984;147:410-413
39.
Spiro MJ, Janiak BD: Spontaneous rupture of the sigmoid colon in a patient with Ehlers-Danlos syndrome . Ann Emerg Med1984;13:960-962
40.
Krieg T., Ihme A., Weber L., et al: Molecular defects of collagen metabolism in Ehlers-Danlos syndrome . Int J Dermatol1981;20:415-425
41.
Harris SC, Slater DN, Austin CA: Fatal splenic rupture in Ehlers-Danlos syndrome. Postgrad Med J1985;61:259-260
42.
Graf CJ: Spontaneous carotid-cavernous fistula: Ehlers-Danlos syndrome and related conditions. Arch Neurol1965;13:662-672
43.
Pretorius ME , Butler IJ: Neurologic manifestations of Ehlers-Danlos syndrome. Neurology (NY) 1983;33: 1087-1089
44.
Sheiner N., Miller N., Lachance C.: Arterial complications of Ehlers-Danlos syndrome. J Cardiovasc Surg1985;26:291-296
45.
Nardone DA, Reuler JB, Girard DE: Gastrointestinal complications of Ehlers-Danlos syndrome. N Engl J Med1979;300:863-864
46.
Smith GB, Shribman AJ: Anaesthesia and severe skin disease. Anaesthesia1984;39:443-455
Elsas LJ, Miller RL, Pinnell SR: Inherited human collagen lysyl hydroxylase deficiency: Ascorbic acid response . J Pediatr1978;92:378-384
49.
Murad S., Grove D., Lindberg KA, et al: Regulation of collagen synthesis by ascorbic acid. Proc Natl Acad Sci USA1981;78:2879-2882
50.
Bagel J., Grossman ME: Hemorrhagic bullae associated with Morganella morganii septicemia . J Am Acad Dermatol1985;12:575-576
51.
Wickboldt LG , Sanders CV: Vibrio vulnifucus infection: Case report and update since 1970. J Am Acad Dermatol1983;9:243-251
52.
Myskowski PL , Brown AE, Dinsmore R., et al: Mucormycosis following bone marrow transplantation. J Am Acad Dermatol1983;9:111-115
53.
Wolfson JS, Sober AJ, Rubin RH: Dermatologic manifestations of infections in immunocompromised patients . Medicine (Baltimore) 1985;64:115-133
54.
Schlossberg D., Ricci JA, Fugate JS: Dermatologic manifestations of Citrobacter septicemia. J Am Acad Dermatol1981;5:613-615
55.
Robboy SJ, Mihm MC, Colman RW, et al: The skin in disseminated intravascular coagulation: Prospective analysis of thirty-six cases. Br J Dermatol1973; 88:221-229
56.
Shelley WB, Zolin WD: Disseminate intradermal bacterial colonization presenting as palpable purpura in lymphoblastic leukemia. J Am Acad Dermatol1983;8:714-717
57.
Wolinsky S. , Grossman ME, Walther RR, et al: Hemorrhagic bullae associated with salmonella septicemia. NY State J Med1981 ;81:1639-1641
58.
Edwards JE, Lehrer RI, Stiehm ER, et al: Severe candidal infections: Clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med1978;89:91-106
59.
Fine JD, Miller JA, Harrist TJ, et al: Cutaneous lesions in disseminated candidiasis mimicking ecthyma gangrenosum. Am J Med1981;70:1133-1135
60.
Roberts R., Tarpay MM, Marks MI, et al: Erysipelas-like lesions and hyperesthesia as manifestations of Pseudomonas aeruginosa sepsis. JAMA1982 ;248: 2156-2157
61.
Musher DM: Cutaneous and soft tissue manifestations of sepsis due to gram-negative enteric bacilli. Rev Infect Dis1980;2:854-866
62.
Yancey KB, Lawley TJ: Circulating immune complexes: Their immunochemistry, biology, and detection in selected dermatologic and systemic diseases. J Am Acad Dermatol1984;10:711-731
63.
Gregoratos G., Karliner JS: Infective endocarditis: Diagnosis and management . Med Clin North Am1979;63:173-199
64.
Ginsburg CM : Hemophilus influenzae type B buccal cellulitis . J Am Acad Dermatol1981;4:661-664
65.
Goldgeier MK : The microbial evaluation of acute cellulitis . Cutis1983;31:649-656
66.
Varghese R. , Melo JC, Chun C., et al: Erysipelas-like syndrome caused by Streptococcus pneumoniae. South Med J1979 ;72:757-758
67.
Binnick AN, Klein RB, Baughman RD: Recurrent erysipelas caused by group B streptococcus organisms. Arch Dermatol1980;116:798-799
68.
Shama S., Calandra GB: A typical erysipelas caused by group G streptococci in a patient with cured Hodgkin's disease. Arch Dermatol1982 ;118:934-936
69.
Olbrych TG, Zarconi J., File TM Jr, et al: Bullous skin lesions associated with Yersinia enterocolitica septicemia. Am J Med Sci1984;287:38-39
70.
Greene SL, Su WPD, Muller SA: Ecthyma gangrenosum: Report of clinical, histopathologic, and bacteriologic aspects of eight cases. J Am Acad Dermatol1984;11:781-787
71.
Salem LD, Zaske D., Strate RG: Ecthyma gangrenosum: Survival with individualized antibiotic therapy . Arch Surg1979;114:580-583
72.
Baze P., Thyss A., Caldani C., et al: Pseudomonas aeruginosa O-11 folliculitis. Arch Dermatol1985; 121:873-876
73.
Turnbull D. , Parry MF: Ecthyma-like skin lesions caused by Staphylococcus aureus. Arch Intern Med1981;141:689
Prystowsky SD, Vogelstein B., Ettinger DS, et al: Invasive aspergillosis . N Engl J Med1976;295:655-658
76.
Lehrer RI, Howard DH, Sypherd PS, et al: Mucormycosis. Ann Intern Med1980;93:93-108
77.
Hook EW III, Holmes KK: Gonococcal infections. Ann Intern Med1985;102:229-243
78.
Black PH, Kunz LJ, Swartz MN: Salmonellosis—a review of some unusual aspects. N Engl J Med1960;262:921-927
79.
Grossman ME , Silvers DN, Walther RR: Cutaneous. manifestations of disseminated candidiasis. J Am Acad Dermatol1980;2:111-116
80.
Wasserman GS , Anderson PC: Loxoscelism and necrotic arachynoidism . J Toxicol Clin Toxicol1983-84;21:451-572
81.
Nance WE: Hemolytic anemia of necrotic arachynoidism. Am J Med1961;31:801-807
82.
Wasserman GS , Siegel CJ: Loxoscelism (brown recluse spider bites): A review of literature. Clin Toxicol1979;14:353-358
83.
Madrigal G. , Ercolani R., Wenzl J.: Toxicity from a bite of the brown spider . Clin Pediatr (Phila ) 1972; 11:641-644
84.
Taylor EM, Denny W.: Hemolysis, renal failure and death, presumed secondary to the bite of brown recluse spider. South Med J1966;59:1209-1211
85.
Auer A., Hershey F.: Surgery for necrotic bites of the brown spider. Arch Surg1974;108:612
86.
Butz W.: Envenomation by the brown recluse spider and related species. Clin Toxicol1971;4:515
87.
Hall RD, Anderson PC: Brown recluse spider bites: Can they be prevented?Mo Med1981;78:243-247
88.
Rees RS, O'Leary JP, King LE: The pathogenesis of systemic loxoscelism following brown recluse spider bites . J Surg Res1982;35:1-10
89.
Anderson PC : Necrotizing spider bites. Am Fam Physician1982;26:198-203
90.
Hagen MD: Urticaria in loxoscelism. South Med J1981 ;74:1427
91.
Forrester LJ , Barrett JT, Campbell BJ: Red blood cell lysis induced by the venom of the brown recluse spider: The role of sphingomyelinase D. Arch Biochem Biophys1978;187:364-365
92.
Sauer G.: Transverse myelitis and paralysis from a brown recluse spider bite . Mo Med1975;72:603-604
93.
Berger RS: A critical look at therapy for the brown recluse spider bite. Arch Dermatol1973;107:298
94.
Rees R., Shack B., Whithers E., et al: Management of the brown recluse spider bite. Plast Reconstr Surg1981;68:768-773
95.
King LE, Rees RS: Dapsone treatment of a brown recluse bite. JAMA1983;250:648
96.
Wesley RE, Ballinger WH, Close LW, et al: Dapsone in the treatment of presumed brown recluse spider bite of the eyelid. Ophthalmic Surg1985;16:116-120
97.
Burger RS: Management of brown recluse spider bite. JAMA1984;251:889-890
